AKT1 and ischemic stroke: Tetramethylpyrazine protects Bone Mesenchymal Stem Cells (BMSC) against H2O2-induced apoptosis via activation of the PI3K/AKT pathway; this was used to improve cell survival in combination with BMSCs in ischemic stroke (102).